Literature DB >> 3316026

In vivo colonization of the mouse large intestine and in vitro penetration of intestinal mucus by an avirulent smooth strain of Salmonella typhimurium and its lipopolysaccharide-deficient mutant.

J J Nevola1, D C Laux, P S Cohen.   

Abstract

The relative abilities of an avirulent Salmonella typhimurium strain with wild-type lipopolysaccharide (LPS) character, SL5319, and a nearly isogenic LPS-deficient mutant, SL5325, to colonize the large intestines of streptomycin-treated CD-1 mice in vivo and to penetrate colonic mucus in vitro were studied. Previously it had been shown that, when fed simultaneously to streptomycin-treated mice (approximately 10(10) CFU each), the S. typhimurium strain with wild-type LPS colonized at 10(8) CFU/g of feces indefinitely, whereas the LPS-deficient mutant dropped within 3 days to a level of only 10(4) CFU/g of feces. In the present investigation, when SL5325 was allowed to colonize for 8 days before feeding mice SL5319 or when it was fed to mice simultaneously with an Escherichia coli strain of human fecal origin (10(10) CFU each), both strains colonized indefinitely at 10(7) CFU/g of feces. Moreover, when the wild-type and LPS-deficient mutant strains were fed to mice simultaneously in low numbers (approximately 10(5) CFU each) the strains survived equally well in the large intestines for 8 days, after which the LPS-deficient mutant was eliminated (less than 10(2) CFU/g of feces), whereas the wild-type colonized at a level of 10(7) CFU/g of feces. In addition although both strains were able to adhere to mucus and epithelial cell preparations in vitro, the wild-type strain was shown to have greater motility and chemotactic activity on CD-1 mouse colonic mucus in vitro and to more rapidly penetrate and form a stable association with immobilized colonic mucosal components in vitro. Based on these data, we suggest that the ability of an S. typhimurium strain to colonize the streptomycin-treated mouse large intestine may, in part, depend on its ability to penetrate deeply into the mucus layer on the intestinal wall and subsequently, through growth, colonize the mucosa.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316026      PMCID: PMC260002          DOI: 10.1128/iai.55.12.2884-2890.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Antibacterial mechanisms of the mouse gut. II. The role of Eh and volatile fatty acids in the normal gut.

Authors:  G G MEYNELL
Journal:  Br J Exp Pathol       Date:  1963-04

2.  Intestinal glycoproteins of germfree rats. Chemical composition of intestinal and fecal mucus from germfree rats fed a chemically defined diet.

Authors:  J K Wold; R Khan; T Midtvedt
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

3.  Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies.

Authors:  R Freter; P C O'Brien; M S Macsai
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

4.  Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies.

Authors:  R Freter; B Allweiss; P C O'Brien; S A Halstead; M S Macsai
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

5.  Lipid composition of the gastric mucous barrier in the rat.

Authors:  A Slomiany; S Yano; B L Slomiany; G B Glass
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

6.  Survival and implantation of Escherichia coli in the intestinal tract.

Authors:  R Freter; H Brickner; J Fekete; M M Vickerman; K E Carey
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

7.  Continuous-flow cultures as in vitro models of the ecology of large intestinal flora.

Authors:  R Freter; E Stauffer; D Cleven; L V Holdeman; W E Moore
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Altered colonizing ability for mouse large intestine of a surface mutant of a human faecal isolate of Escherichia coli.

Authors:  M L Myhal; P S Cohen; D C Laux
Journal:  J Gen Microbiol       Date:  1983-05

9.  RESISTANCE OF THE MOUSE'S INTESTINAL TRACT TO EXPERIMENTAL SALMONELLA INFECTION. II. FACTORS RESPONSIBLE FOR ITS LOSS FOLLOWING STREPTOMYCIN TREATMENT.

Authors:  M BOHNHOFF; C P MILLER; W R MARTIN
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

10.  Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.

Authors:  R FRETER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

View more
  23 in total

1.  Mouse intestine selects nonmotile flhDC mutants of Escherichia coli MG1655 with increased colonizing ability and better utilization of carbon sources.

Authors:  Mary P Leatham; Sarah J Stevenson; Eric J Gauger; Karen A Krogfelt; Jeremy J Lins; Traci L Haddock; Steven M Autieri; Tyrrell Conway; Paul S Cohen
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Role of anaerobiosis in virulence of Salmonella typhimurium.

Authors:  R D Singh; M Khullar; N K Ganguly
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

3.  Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.

Authors:  Qingke Kong; Jiseon Yang; Qing Liu; Praveen Alamuri; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

4.  Murein lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar typhimurium systemic infection.

Authors:  A A Fadl; J Sha; G R Klimpel; J P Olano; D W Niesel; A K Chopra
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  Roles of motility, chemotaxis, and penetration through and growth in intestinal mucus in the ability of an avirulent strain of Salmonella typhimurium to colonize the large intestine of streptomycin-treated mice.

Authors:  B A McCormick; B A Stocker; D C Laux; P S Cohen
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Intestinal mucins: the binding sites for Salmonella typhimurium.

Authors:  D B Vimal; M Khullar; S Gupta; N K Ganguly
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

7.  Salmonella choleraesuis strains deficient in O antigen remain fully virulent for mice by parenteral inoculation but are avirulent by oral administration.

Authors:  N A Nnalue; A A Lindberg
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

8.  Interactions between Yersinia enterocolitica and rabbit ileal mucus: growth, adhesion, penetration, and subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles.

Authors:  A Paerregaard; F Espersen; O M Jensen; M Skurnik
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  The Pic protease of enteroaggregative Escherichia coli promotes intestinal colonization and growth in the presence of mucin.

Authors:  Susan M Harrington; Jalaluddin Sheikh; Ian R Henderson; Fernando Ruiz-Perez; Paul S Cohen; James P Nataro
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

10.  L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium.

Authors:  Steven M Autieri; Jeremy J Lins; Mary P Leatham; David C Laux; Tyrrell Conway; Paul S Cohen
Journal:  Infect Immun       Date:  2007-08-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.